Cancer Clinic

The Poursina Hakim Cancer Clinic

The Poursina Hakim Cancer Clinic (PHCC), a subset of Poursina Hakim Holding Company, is a multidisciplinary leading organization for gastrointestinal (GI) and breast cancer research, prevention, screening, diagnosis, and treatment. The PHCC is dedicated to a comprehensive evaluation of patients by a multidisciplinary team of the top clinicians and specialists in the country comprising of gastroenterologist, internal medicine specialist, medical oncologist, surgical oncologist, chemotherapist, pathologist, nutritionist, psychiatrist, molecular medicine specialist and basic and clinical researchers. Our professional team work together to provide you with the best possible integrated care and treatment. Conventional treatments like surgery, chemotherapy, and radiation therapy are used to attack the cancer. At the same time, evidenced-informed supportive therapies like nutritional support and physicological therapy help patients combat treatment-related side effects, to help them build the strength and resilience to fight the disease.

Cooperating with some other medical centers of country, PHCC has been trying to create a comprehensive colorectal Biorepository (clinical – Para clinical) service for patients with colorectal cancer and adenoma since 2015. Furthermore, considering that cancer registry is an essential part of cancer prevention and control, PHCC established the colorectal cancer (CRC) registry in 2018 to develop strategies and policies for CRC screening, prevention, treatment and control. In addition, the Cancer Society of Iran opened its official office in 2018 at the Pursinai Hakim cancer clinic. Moreover, the Pourishina Hakim cancer non-governmental organization (NGO) has started its activities in 2004.

Director:

Seyed Mohammad Hassan Emami, prof. MD, Subspeciality in Gastroenterology and Hepatology

Scientific advisors board:

Alireza Fahim, MD, Internist, Gastroenterology and Hepatology

Hojatallah Rahimi, MD, Internist, Gastroenterology and Hepatology

Elham Amjadi, Anatomical and Clinical Pathologist

Baharm Bagherpour, MD, Molecular Medicine Specialist

Pouria Adeli, MD, oncologist

Seyed Mohamad Reza Hakimian, MD, Surgeon, Surgical Oncology Fellowship

Maryam Pourbafrani, MD, Psychiatrist

Abodolmehdi Baghaei, MD, Internist

Shadi Kazemi, internist

Golnar Rozati, internist

Reza Solouki, General practitioner

Fateme Maghool, PhD, physiologist

Nahid Jamali, MBA

Leyla Loghmani, BS, Nutritionist

Our team of GI cancer experts at Poursina Hakim Cancer Clinic provide innovative diagnostic and treatment services for gastrointestinal malignancies. These include cancers of the esophagus, stomach, gallbladder, liver, pancreas, small intestine and colon. The PHCC specialists offer the following diagnostic and treatment services:

  • Surgery of gastrointestinal malignancies
  • Colonoscopy/polypectomy
  • Endoscopic mucosal ablation and resection of Barrett’s esophagus using endoscopic mucosal resection (EMR)
  • EMR for the treatmentof early gastrointestinal cancer and precancerous lesions
  • Liver resection
  • Medical oncology services
  • Laparoscopic T-tube feeding jejunostomy as an adjunct to staging laparoscopy for upper gastrointestinal malignancies
  • Biliary bypass
  • Stent placement for esophageal, duodenal, biliary and colorectal obstructions
  • Endoscopic submucosal dissection for gastrointestinal neoplasms
  • ERCP (Endoscopic Retrograde Cholangio-Pancreatography)for diagnose and treat bile duct cancer, as well as some cancers of the liver, gallbladder and pancreas
  • Chemotherapy

Colorectal cancer can often start with no symptoms, so health experts recommend screening for CRC even in seemingly healthy individuals. For this purpose, in addition to performing specialized molecular diagnostic screening tests of colorectal cancers such as MSI, MSH2, MSH6, PMS2,M LH1, KRAS, and BRAF, the PHCC has launched a comprehensive range of prevention programs, Colorectal Cancer Registry and Repository, for the CRC screening and prevention. In line with the stated goals, the Pourishina Hakim cancer non-governmental organization (NGO) has started its activities, and the Cancer Society of Iran opened its official office at the PHCC as well.

Experts at PHCC help the patients understand their individual risk of developing colorectal cancer and develop a CRC prevention plan specifically for their lifestyle such as diet and exercise, family history of cancer, and other factors.

The Colorectal Cancer Registry:

Colorectal cancer (CRC) can be treated if early diagnosed and promptly treated. It also can be almost prevented with behavioral or lifestyle changes. Clinical cancer registries are an essential tool to characterize this malignancy. In the CRC registry of the PHCC, medical data of CRC patients is documented over the course of disease. So it plays a key role in developing strategies and policies for prevention, diagnostic, treatment, and control of CRC. Furthermore, data of the CRC registry, a separate database for scientific commitments, can be used for different research projects. Therefore, the major objective of our clinical cancer registry is to continuously monitor and assesse the effectiveness of colorectal cancer control activities and improve the treatment of CRC.

The Colorectal Cancer Repository

The Poursina Hakim Cancer Clinic has begun its activities with several healthcare centers throughout the country since 2015 to create a comprehensive database (clinical-paraclinical) for patients with any type of adenoma and colorectal cancer. The aims of CRC repository include:

  1. Establishing a comprehensive database and identifying mutations involved in the disease process, will facilitate access to diagnostic markers for CRC patients and the disease control in Iran.
  2. Providing the possibility of studying the biological-pathological differences in CRC and adenoma among different parts of Iran.
  3. Quantitative and qualitative improvements of genetic and epigenetic studies associated with adenoma and colorectal cancer.
  4. Achieving diagnostic methods at lower cost, more sensitivity and more specific.
  5. Achieving non-invasive diagnostic methods for early detection of CRC.

The Iranian Cancer Association (Central branch) 

The Iranian Cancer Society Office was formally established in june 2018 at the PHCC and Professor Mohammad Hasan Emami was appointed as Chairman of the Board of Directors of the Iranian Cancer Association (Central branch). The Iranian Cancer Association has begun activities on cancer prevention and treatment with a team vision, and in this regard, it continues its accomplishments with the presence of the best specialists in the various fields involved in the diagnosis and treatment of cancer.

The Poursina Hakim cancer non-governmental organization (PHC-NGO)

The Poursina Hakim cancer NGO has started its activities in 2004. Since its creation, the PHC NGO has committed itself not only to education and training in screening/early detection, diagnosis, and treatment of gastrointestinal and breast cancers, but also to conduct extensive research in cooperation with various scientific research groups in the areas described above.

The PHC-NGO set its goal on the basis of a fundamental struggle with risky behaviors, early cancer detection, and timely treatments. We believe that this goal will not be carried out except through extensive and comprehensive research in a variety of areas. Hence, a group of prominent scholars and experts at the Poursina Hakim cancer clinic came together and started their studies in various fields of epidemiology, nutrition, environmental issues, prevention, screening, early diagnosis, treatment, and psychological issues related to cancer and its prognosis, and now these studies are also active in the form of specialized teams. The PHC-NGO has also conducted extensive training activities in the fields of screening, prevention and treatment of cancer.

  • Special training activities for the medical community
  • Special education activities for the general public
  • Educational programs on social media
  • Epidemiological studies in Isfahan province
  • Collaboration with Shahrekord University in conducting epidemiological studies
  • Clinical studies related to the patients referred to the Poursina Hakim clinic
  • Contributing to the University of Amir Kabir to find predictive markers of cancer
  • Participation with the Department of Genetics of Isfahan University of Medical Sciences for early diagnosis of cancer
  • Participation with the Faculty of Pharmacy of Isfahan University of Medical Sciences to conduct pancreatic cancer research,

and numerous studies on the distribution of cancer in Isfahan province, nutrition and cancer and etc.

We believe that cancer care extends well beyond your initial medical treatment. We offer support services ranging from nutrition to psychological counseling. We are confident that the support and care that we give to each of our patients, is absolutely critical.